On the other side, another immunohistochemical research reported that ZHX2 was highly expressed in tumor samples compared to adjacent tissues in HCC patients, and the prognostic analysis showed ZHX2 was associated with poorer outcomes17, seems it act as an oncogenic biomarker. Here, ZHX2 is linked to neoplasm.